RESISTANT HYPERTЕNSION PATIENT WITH PRIMARY ALDOSTERONISM

N V Ivanova , V P Aerinchek , Y N Grishkin

HERALD of North-Western State Medical University named after I.I. Mechnikov ›› 2015, Vol. 7 ›› Issue (1) : 147 -151.

PDF
HERALD of North-Western State Medical University named after I.I. Mechnikov ›› 2015, Vol. 7 ›› Issue (1) :147 -151. DOI: 10.17816/mechnikov201571147-151
Reviews
research-article

RESISTANT HYPERTЕNSION PATIENT WITH PRIMARY ALDOSTERONISM

Author information +
History +
PDF

Abstract

Mineralocorticoid hypertension, including Conn's syndrome, occurs significantly more frequently than is recognized. Despite modern diagnostic capabilities and the availability of treatment methods, it cannot be diagnosed simply because (they) know little about it. Recall clinico-pathological variants of mineralocorticoid hypertension and the peculiarities of their management. Here is a fairly typical clinical case Conn's syndrome, recognized for many years later than it needed to be done. Pay attention to the fact that mineralocorticoid hypertension should be considered in patients with resistant nature of the response to treatment.

Keywords

arterial hypertension / secondary hypertension. mineralocorticoid hypertension / Conn's syndrome

Cite this article

Download citation ▾
N V Ivanova, V P Aerinchek, Y N Grishkin. RESISTANT HYPERTЕNSION PATIENT WITH PRIMARY ALDOSTERONISM. HERALD of North-Western State Medical University named after I.I. Mechnikov, 2015, 7(1): 147-151 DOI:10.17816/mechnikov201571147-151

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Емельянов, И.В. Резистентная артериальная гипертензия: определение, эпидемиология и этиология / И.В. Емельянов, А.О. Конради // В книге «Резистентная артериальная гипертензия» (под ред. проф. Е.В. Шляхто). - СПб, 2012. - С. 5-25.

[2]

Мазуров, В.И. Артериальная гипертензия: этиология, патогенез, клиника и лечение / В.И. Мазуров, Ю.Н. Гришкин, Н.В. Иванова, В.А. Якушева // Бюлл. С.-Петерб. ассоц. врачей-терапевтов. - 2004. - №1. - С.4-25.

[3]

Biglieri, E.G. Primary aldosteronism / E.G. Biglieri //Curr Ther Endocrinology Metab. - 1977. - V. 6. - P.170-172.

[4]

Calhoun, D.A. Hyperaldosteronism among black and white subjects with resistant hypertension / D.A. Calhoun, M.K. Nishizaka, M.A. Zaman et al. // Hypertension.-2002.- V. 40. - № 6.-P. 892-896.

[5]

Douma, S. Prevalence of primary hyperaldosteronism in resistent hypertension: a retroshective observation study / S. Douma, K. Petidis, M. Doumas et al. // The Lancet. - 2008. - V. 371. - № 9628. - P. 1921-1926.

[6]

Gordon, R. Clinical and pathological divercity of primary aldosteronism, including a new familial variety / R. Gordon, M. Stowasser, T. Tunny et al. // Clin Exp Pharmacol Physiol. - 1999. - V. 18. - P. 283-286.

[7]

Gordon, R. Primary aldosteronism: the case for screening / R. Gordon, M. Stowasser // Nat Clin Pract Nephrol. - 2007. - V. 3. - P. 582-583.

[8]

Favia, G. Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients / G. Favia, F. Lumachi, V. Scarpa et al. // World J. Surg. - 1992. - V. 16. - P. 680-683.

RIGHTS & PERMISSIONS

Ivanova N.V., Aerinchek V.P., Grishkin Y.N.

PDF

147

Accesses

0

Citation

Detail

Sections
Recommended

/